"","Total","Expected","Hits","Raw p","-log10(p)","Holm adjust","FDR","Impact"
"Arrhythmogenic right ventricular cardiomyopathy",88,0.57678,5,0.00026553,3.5759,0.092138,0.092138,5.176e-05
"Viral myocarditis",94,0.6161,4,0.003289,2.4829,1,0.43846,0
"Hypertrophic cardiomyopathy",103,0.67509,4,0.0045644,2.3406,1,0.43846,0
"Dilated cardiomyopathy",106,0.69476,4,0.0050542,2.2963,1,0.43846,0
"Human cytomegalovirus infection",260,1.7041,6,0.0069195,2.1599,1,0.48021,0.001174
"Pentose phosphate pathway",71,0.46536,3,0.011176,1.9517,1,0.64637,0.033384
"Antigen processing and presentation",87,0.57022,3,0.019254,1.7155,1,0.95446,0.019915
"Cardiac muscle contraction",93,0.60955,3,0.022932,1.6396,1,0.99466,0
"Cell adhesion molecules",179,1.1732,4,0.029577,1.529,1,1,0
"Vasopressin-regulated water reabsorption",46,0.3015,2,0.03638,1.4391,1,1,0
"Base excision repair",47,0.30805,2,0.037839,1.4221,1,1,0
"TNF signaling pathway",118,0.77341,3,0.042073,1.376,1,1,0.00018315
"Fanconi anemia pathway",52,0.34082,2,0.045463,1.3423,1,1,0
"Herpes simplex virus 1 infection",216,1.4157,4,0.052849,1.277,1,1,0.00023132
"Allograft rejection",61,0.39981,2,0.060452,1.2186,1,1,0
"Inflammatory bowel disease",62,0.40637,2,0.06221,1.2061,1,1,0
"Graft-versus-host disease",62,0.40637,2,0.06221,1.2061,1,1,0
"Signaling pathways regulating pluripotency of stem cells",140,0.9176,3,0.063843,1.1949,1,1,0.001052
"Basal cell carcinoma",64,0.41948,2,0.065778,1.1819,1,1,0.033333
"Type I diabetes mellitus",70,0.4588,2,0.076877,1.1142,1,1,0
"Human immunodeficiency virus 1 infection",246,1.6124,4,0.077365,1.1115,1,1,0.00089777
"Non-homologous end-joining",13,0.085206,1,0.081984,1.0863,1,1,0
"Hippo signaling pathway",158,1.0356,3,0.084817,1.0715,1,1,0.0066977
"Human papillomavirus infection",362,2.3727,5,0.087933,1.0558,1,1,0.00039308
"Adrenergic signaling in cardiomyocytes",166,1.088,3,0.094978,1.0224,1,1,0
"Autoimmune thyroid disease",80,0.52434,2,0.096557,1.0152,1,1,0
"Cytosolic DNA-sensing pathway",84,0.55056,2,0.10479,0.97966,1,1,0.001747
"Cushing syndrome",175,1.147,3,0.10698,0.9707,1,1,0.0014093
"Prion disease",278,1.8221,4,0.10879,0.96339,1,1,0.0018307
"Peroxisome",87,0.57022,2,0.11109,0.95431,1,1,0
"Pertussis",87,0.57022,2,0.11109,0.95431,1,1,0
"Phagosome",184,1.206,3,0.11954,0.92247,1,1,0
"Cytokine-cytokine receptor interaction",294,1.927,4,0.12639,0.8983,1,1,0
"Valine, leucine and isoleucine degradation",99,0.64888,2,0.13721,0.8626,1,1,0.31822
"Tuberculosis",198,1.2978,3,0.14012,0.8535,1,1,0.00016101
"Fatty acid degradation",102,0.66854,2,0.14395,0.8418,1,1,1.0508
"Huntington disease",314,2.0581,4,0.14996,0.82403,1,1,0
"Melanogenesis",106,0.69476,2,0.15303,0.81523,1,1,0.0063425
"Maturity onset diabetes of the young",27,0.17697,1,0.16288,0.78813,1,1,0
"TGF-beta signaling pathway",111,0.72753,2,0.16453,0.78375,1,1,0.00042955
"Prostate cancer",111,0.72753,2,0.16453,0.78375,1,1,0.0032787
"Toxoplasmosis",112,0.73408,2,0.16685,0.77766,1,1,0.00076805
"Asthma",30,0.19663,1,0.17928,0.74646,1,1,0
"Kaposi sarcoma-associated herpesvirus infection",228,1.4944,3,0.18776,0.7264,1,1,0.00046264
"RNA polymerase",32,0.20974,1,0.19004,0.72116,1,1,0
"Epstein-Barr virus infection",231,1.514,3,0.19274,0.71502,1,1,0.00019157
"Glycosaminoglycan biosynthesis - chondroitin sulfate or dermatan sulfate",33,0.21629,1,0.19537,0.70915,1,1,0
"Aldosterone synthesis and secretion",125,0.81929,2,0.19749,0.70446,1,1,0.0038444
"Cholinergic synapse",125,0.81929,2,0.19749,0.70446,1,1,0.013934
"Glycosaminoglycan biosynthesis - heparan sulfate or heparin",35,0.2294,1,0.20592,0.68631,1,1,0
"Pancreatic secretion",130,0.85206,2,0.20946,0.6789,1,1,0
"Staphylococcus aureus infection",130,0.85206,2,0.20946,0.6789,1,1,0.00067476
"DNA replication",36,0.23596,1,0.21114,0.67543,1,1,0
"Primary immunodeficiency",36,0.23596,1,0.21114,0.67543,1,1,0
"Nitrogen metabolism",37,0.24251,1,0.21633,0.66489,1,1,0.00046253
"Thyroid cancer",37,0.24251,1,0.21633,0.66489,1,1,0.0033333
"Tryptophan metabolism",135,0.88483,2,0.22151,0.65461,1,1,0.0054603
"cAMP signaling pathway",249,1.632,3,0.22332,0.65107,1,1,0.069241
"Relaxin signaling pathway",136,0.89139,2,0.22393,0.6499,1,1,0.039767
"Human T-cell leukemia virus 1 infection",252,1.6517,3,0.22852,0.64108,1,1,0.00017889
"Diabetic cardiomyopathy",256,1.6779,3,0.23548,0.62805,1,1,4.7893e-05
"Salmonella infection",257,1.6845,3,0.23723,0.62484,1,1,0.00073964
"Thermogenesis",261,1.7107,3,0.24424,0.61219,1,1,0.0055098
"Dopaminergic synapse",148,0.97004,2,0.25307,0.59676,1,1,0.0089984
"Intestinal immune network for IgA production",45,0.29494,1,0.25666,0.59065,1,1,0
"Breast cancer",150,0.98315,2,0.25794,0.58848,1,1,0.0014706
"Thiamine metabolism",46,0.3015,1,0.26155,0.58244,1,1,0.0064011
"Systemic lupus erythematosus",153,1.0028,2,0.26526,0.57633,1,1,0
"Folate transport and metabolism",47,0.30805,1,0.26641,0.57444,1,1,0
"Ubiquitin mediated proteolysis",154,1.0094,2,0.2677,0.57236,1,1,0
"Gastric cancer",154,1.0094,2,0.2677,0.57236,1,1,0.0024748
"Glycosaminoglycan degradation",48,0.31461,1,0.27125,0.56664,1,1,0.001773
"Cocaine addiction",56,0.36704,1,0.30879,0.51034,1,1,0.0040123
"JAK-STAT signaling pathway",171,1.1208,2,0.30909,0.50992,1,1,0.0014401
"Nucleotide excision repair",58,0.38015,1,0.31787,0.49775,1,1,0
"Wnt signaling pathway",176,1.1536,2,0.3212,0.49323,1,1,0.061542
"Endometrial cancer",59,0.3867,1,0.32237,0.49164,1,1,0.0038647
"Influenza A",177,1.1601,2,0.32362,0.48997,1,1,0
"Cholesterol metabolism",60,0.39326,1,0.32684,0.48566,1,1,0
"cGMP-PKG signaling pathway",182,1.1929,2,0.33567,0.47409,1,1,0
"beta-Alanine metabolism",64,0.41948,1,0.34443,0.4629,1,1,0.0085022
"Primary bile acid biosynthesis",65,0.42603,1,0.34875,0.45748,1,1,5.7195e-05
"Hepatocellular carcinoma",189,1.2388,2,0.35244,0.45291,1,1,0.0015935
"alpha-Linolenic acid metabolism",69,0.45225,1,0.36578,0.43678,1,1,0.0033937
"Fatty acid elongation",69,0.45225,1,0.36578,0.43678,1,1,1.3916
"Regulation of lipolysis in adipocytes",71,0.46536,1,0.37412,0.42699,1,1,0
"Acute myeloid leukemia",71,0.46536,1,0.37412,0.42699,1,1,0
"Propanoate metabolism",73,0.47846,1,0.38236,0.41753,1,1,0.041779
"RIG-I-like receptor signaling pathway",74,0.48502,1,0.38644,0.41292,1,1,0
"Butanoate metabolism",74,0.48502,1,0.38644,0.41292,1,1,0.033898
"Leishmaniasis",76,0.49813,1,0.39452,0.40393,1,1,0
"Bacterial invasion of epithelial cells",77,0.50468,1,0.39852,0.39955,1,1,0.0011074
"Proteoglycans in cancer",211,1.383,2,0.40416,0.39345,1,1,0.00012563
"Amphetamine addiction",79,0.51779,1,0.40644,0.391,1,1,0.0023338
"Alcoholism",217,1.4223,2,0.41794,0.37888,1,1,0.0070707
"RNA degradation",83,0.54401,1,0.42198,0.37471,1,1,0
"Cortisol synthesis and secretion",84,0.55056,1,0.4258,0.37079,1,1,0.0014027
"NOD-like receptor signaling pathway",222,1.4551,2,0.42931,0.36723,1,1,0.0021386
"Prolactin signaling pathway",85,0.55712,1,0.4296,0.36694,1,1,0
"Pathways of neurodegeneration - multiple diseases",513,3.3624,4,0.43579,0.36073,1,1,0.00020202
"Glycine, serine and threonine metabolism",88,0.57678,1,0.44084,0.35572,1,1,0.048516
"Viral carcinogenesis",228,1.4944,2,0.44281,0.35379,1,1,0
"Colorectal cancer",89,0.58333,1,0.44454,0.35209,1,1,0.0038874
"ECM-receptor interaction",90,0.58989,1,0.44821,0.34851,1,1,0
"Rheumatoid arthritis",90,0.58989,1,0.44821,0.34851,1,1,0
"Cytoskeleton in muscle cells",232,1.5206,2,0.45171,0.34514,1,1,0
"Th1 and Th2 cell differentiation",91,0.59644,1,0.45187,0.34499,1,1,0
"Adherens junction",92,0.603,1,0.45549,0.34152,1,1,0
"Renin secretion",93,0.60955,1,0.4591,0.3381,1,1,0
"PPAR signaling pathway",94,0.6161,1,0.46268,0.33472,1,1,0
"Hematopoietic cell lineage",94,0.6161,1,0.46268,0.33472,1,1,0
"Viral protein interaction with cytokine and cytokine receptor",95,0.62266,1,0.46623,0.3314,1,1,0
"Thyroid hormone synthesis",95,0.62266,1,0.46623,0.3314,1,1,0.00027996
"Regulation of actin cytoskeleton",239,1.5665,2,0.4671,0.33059,1,1,0.0037423
"Glyoxylate and dicarboxylate metabolism",96,0.62921,1,0.46977,0.32812,1,1,0.0029963
"Amyotrophic lateral sclerosis",389,2.5496,3,0.47217,0.32591,1,1,0
"Longevity regulating pathway",98,0.64232,1,0.47676,0.3217,1,1,0
"Insulin secretion",98,0.64232,1,0.47676,0.3217,1,1,0.0015664
"GABAergic synapse",99,0.64888,1,0.48023,0.31855,1,1,0.0045455
"Glycerolipid metabolism",101,0.66199,1,0.48709,0.31239,1,1,0.0078321
"mRNA surveillance pathway",104,0.68165,1,0.49722,0.30345,1,1,0
"Morphine addiction",104,0.68165,1,0.49722,0.30345,1,1,0.0021212
"Central carbon metabolism in cancer",106,0.69476,1,0.50386,0.29769,1,1,0
"Alzheimer disease",408,2.6742,3,0.50415,0.29744,1,1,0.00035377
"Circadian entrainment",108,0.70787,1,0.51041,0.29208,1,1,0.018905
"Th17 cell differentiation",109,0.71442,1,0.51366,0.28933,1,1,0
"NF-kappa B signaling pathway",110,0.72097,1,0.51688,0.28661,1,1,0
"Glutathione metabolism",111,0.72753,1,0.52008,0.28393,1,1,0.0048309
"Calcium signaling pathway",265,1.7369,2,0.522,0.28233,1,1,0.0058275
"Nucleocytoplasmic transport",118,0.77341,1,0.54193,0.26606,1,1,0
"Bile secretion",275,1.8024,2,0.54212,0.26591,1,1,0
"Lysine degradation",120,0.78652,1,0.54799,0.26123,1,1,0.020927
"Amoebiasis",121,0.79307,1,0.55099,0.25886,1,1,0
"Growth hormone synthesis, secretion and action",121,0.79307,1,0.55099,0.25886,1,1,0.0066964
"Leukocyte transendothelial migration",123,0.80618,1,0.55693,0.2542,1,1,0
"C-type lectin receptor signaling pathway",124,0.81273,1,0.55987,0.25191,1,1,0
"Glutamatergic synapse",124,0.81273,1,0.55987,0.25191,1,1,0.0039124
"Complement and coagulation cascades",125,0.81929,1,0.56279,0.24965,1,1,0
"Parathyroid hormone synthesis, secretion and action",127,0.8324,1,0.56858,0.24521,1,1,0.0032726
"Insulin resistance",130,0.85206,1,0.57712,0.23873,1,1,0.00021786
"Glucagon signaling pathway",130,0.85206,1,0.57712,0.23873,1,1,0.018954
"Thyroid hormone signaling pathway",131,0.85861,1,0.57993,0.23662,1,1,0
"ATP-dependent chromatin remodeling",136,0.89139,1,0.59371,0.22643,1,1,0
"Apoptosis",139,0.91105,1,0.60176,0.22058,1,1,0
"Osteoclast differentiation",139,0.91105,1,0.60176,0.22058,1,1,0.0071405
"Lysosome",140,0.9176,1,0.60441,0.21867,1,1,0
"Estrogen signaling pathway",142,0.93071,1,0.60965,0.21492,1,1,0
"Spinocerebellar ataxia",148,0.97004,1,0.62498,0.20413,1,1,0
"Apelin signaling pathway",148,0.97004,1,0.62498,0.20413,1,1,0.018378
"AMPK signaling pathway",150,0.98315,1,0.62996,0.20069,1,1,0
"Alcoholic liver disease",152,0.99625,1,0.63487,0.19732,1,1,0.00034698
"Oxidative phosphorylation",153,1.0028,1,0.6373,0.19566,1,1,0
"Protein digestion and absorption",155,1.0159,1,0.64211,0.19239,1,1,0
"mTOR signaling pathway",162,1.0618,1,0.65848,0.18146,1,1,0.0013626
"Non-alcoholic fatty liver disease",164,1.0749,1,0.66302,0.17847,1,1,0
"Coronavirus disease - COVID-19",344,2.2547,2,0.66493,0.17723,1,1,0
"Oxytocin signaling pathway",165,1.0815,1,0.66526,0.17701,1,1,0
"Hepatitis B",165,1.0815,1,0.66526,0.17701,1,1,0.00071863
"Retrograde endocannabinoid signaling",172,1.1273,1,0.68059,0.16712,1,1,0.0060241
"Serotonergic synapse",178,1.1667,1,0.69317,0.15916,1,1,0.0019425
"Protein processing in endoplasmic reticulum",181,1.1863,1,0.69927,0.15535,1,1,0
"Axon guidance",182,1.1929,1,0.70128,0.15411,1,1,0
"Efferocytosis",184,1.206,1,0.70526,0.15165,1,1,0.003937
"PI3K-Akt signaling pathway",371,2.4316,2,0.70539,0.15157,1,1,0.0061386
"Cellular senescence",187,1.2257,1,0.71113,0.14805,1,1,0
"ABC transporters",191,1.2519,1,0.71878,0.1434,1,1,0
"Motor proteins",198,1.2978,1,0.73169,0.13568,1,1,0
"Chemokine signaling pathway",198,1.2978,1,0.73169,0.13568,1,1,0.010377
"Steroid hormone biosynthesis",200,1.3109,1,0.73527,0.13356,1,1,0
"Pathways in cancer",579,3.7949,3,0.74022,0.13064,1,1,0.0017753
"Purine metabolism",235,1.5403,1,0.79081,0.10193,1,1,0.031815
"Ras signaling pathway",243,1.5927,1,0.8018,0.095935,1,1,0.00021478
"Chemical carcinogenesis - receptor activation",257,1.6845,1,0.81967,0.086359,1,1,0
"Endocytosis",276,1.809,1,0.84142,0.074987,1,1,0
"Chemical carcinogenesis - reactive oxygen species",286,1.8745,1,0.85181,0.069658,1,1,0
"Parkinson disease",300,1.9663,1,0.86523,0.062867,1,1,0
"MAPK signaling pathway",304,1.9925,1,0.86884,0.061058,1,1,0
"Neuroactive ligand-receptor interaction",445,2.9167,1,0.95003,0.022265,1,1,0
"Olfactory transduction",1219,7.9897,1,0.99981,8.2123e-05,1,1,0.01052
